A comparative analysis of diffusion-weighted magnetic resonance imaging and contrast-enhanced CT in target volume delineation for pancreatic cancer
Han Ruobing,Ren Gang,Yu Huiming,Wang Xuan,Liu Chen,Xai Tingyi,Yu Huiming
Department of Radiation Oncology,Air Force General Hospital,Beijing 100142,China (Han RB,Ren G,Wang X,Liu CH,Xai TY);Department of Radiation Oncology,Beijing Institute of Peking University Cancer Hospital,Beijing 1000142,China (Yu HM)
Abstract：Objective To investigate the differences in tumor volume and metastatic tumors of the liver and regional lymph nodes between contrast-enhanced computed tomography (CT) and diffusion-weighted magnetic resonance imaging (DWMRI) through a comparative analysis,as well the useful information for target volume delineation,and to guide radiotherapy in clinical practice. Methods A total of 40 patients with pancreatic cancer were enrolled and underwent contrast-enhanced CT and DWMRI in the same position. The target volume was delineated,the major axis of the maximum tumor section was measured,and the numbers of liver metastatic tumors and metastatic tumors of the lymph nodes with a diameter of 5-8 mm or>8 mm were measured based on the CT and DWMRI images. The analysis was performed by using paired t-test or paired Wilcoxon rank sum test. Results The mean gross tumor volume (GTV) delineated by contrast-enhanced CT and DWMRI was 54.95 cm3 and 41.67 cm3(P=0.000),and the mean value-different value was 13.28 cm3.The major axis of the maximum tumor section measured by contrast-enhanced CT and DWMRI were 4.18 cm and 3.94 cm (P=0.000),respectively,and in two patients,dCT was smaller than dDWMRI.A total of 83 liver metastatic tumors were identified by contrast-enhanced CT,and 112 were identified by DWMRI;the liver metastatic tumors detected by contrast-enhanced CT accounted for 74% of those detected by DWMRI.As for the metastatic tumors of the lymph nodes with a diameter of 5-8 mm or>8 mm,103 or 46 were detected by contrast-enhanced CT,and 200 or 56 were detected by DWMRI,and the tumors detected contrast-enhanced CT accounted for 52% or 82% of those detected by DWMRI.There were significant differences in all data between contrast-enhanced CT and DWMRI. Conclusions GTV and the major axis of the maximum tumor section measured by DWMRI are lower than those measured by contrast-enhanced CT,and contrast-enhanced CT is sensitive in detecting the metastatic tumors of the liver and lymph nodes. However,it is necessary to conduct further controlled experiments with reference to pathology.
. A comparative analysis of diffusion-weighted magnetic resonance imaging and contrast-enhanced CT in target volume delineation for pancreatic cancer[J]. Chinese Journal of Radiation Oncology, 2016, 25(9): 939-943.
[1] Koutsounas I,Giaginis C,Patsouris E,et al. Current evidence for histone deacetylase inhibitors in pancreatic cancer[J].World J Gastroenterol,2013,19(6):813-828.DOI:10.3748/wjg.v19.i6.813. [2] 夏廷毅,孙庆选,于涌,等.体部γ-刀治疗52例胰腺癌的疗效分析[J].中华肝胆外科志,2006,12(2):86-88.DOI:10.3760/cma.j.issn.1007-8118.2006.02.006. Xia TY,Sun QX,Yu Y,et al. Analysis of clinical outcomes of body gamma knife therapy for 52 patients with advanced pancreatic carcinoma[J].Chin J Hepatobiliary Surg,2006,12(2):86-88.DOI:10.3760/cma.j.issn.1007-8118.2006.02.006. [3] Yechieli R,Robbins JR,Mahan M,et al. Stereotactic body radiation therapy for the treatment of elderly patients with medically inoperable pancreatic cancer[J].Int J Radiat Oncol Biol Phys,2013,87(2S):S305.DOI:10.1016/j.ijrobp.2013.06.802. [4] Thoeny HC,De Keyzer F.Extracranial applications of diffusion-weighted magnetic resonance imaging[J].Eur Radiol,2007,17(6):1385-1393.DOI:10.1007/s00330-006-0547-0. [5] Patterson DM,Padhani AR,Collins DJ.Technology insight:water diffusion MRI-a potential new biomarker of response to cancer therapy[J].Nat Clin Pract Oncol,2008,5(4):220-233.DOI:10.1038/ncponc1073. [6] 徐钐,周四清,温生贵.磁共振弥散加权成像对胰腺囊肿性病变的鉴别诊断价值[J].中华临床医师杂志,2012,6(7):1853-1855.DOI:10.3877/cma.j.issn.1674-0785.2012.07.042. Xu B,Zhou SQ,Wen SHG.Differential diagnostic value of magnetic resonance diffusion weighted imaging in the diagnosis of pancreatic cystic lesions[J].Chin J Clinicians,2012,6(7):1853-1855.DOI:10.3877/cma.j.issn.1674-0785.2012.07.042. [7] Huang WC,Sheng J,Chen SY,et al.differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis:usefulness of high b value diffusion-weighted imaging[J].J Dig Dis,2011,12(5):401-408.DOI:10.1111/j.1751-2980.2011.00517.x. [8] Takeuchi M,Matsuzaki K,Kubo H,et al. High-b-value diffusion-weighted magnetic resonance imaging of pancreatic cancer and mass-forming chronic pancreatitis:preliminary results[J].Acta Radiol,2008,49(4):383-386.DOI:10.1080/02841850801895381. [9] Fattahi R,Balci NC,Perman WH,et al. Pancreatic diffusion-weighted imaging (DWMRI):comparison between mass-forming focal pancreatitis (FP),pancreatic cancer (PC),and normal pancreas[J].J Magn Reson Imaging,2009,29(2):350-356.DOI:10.1002/jmri.21651. [10] Lee SS,Byun JH,Park BJ,et al. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas:usefulness in characterizing solid pancreatic masses[J].J Magn Reson Imaging,2008,28(4):928-936.DOI:10.1002/jmri.21508. [11] Momtahen AJ,Balci NC,Alkaade S,et al. Focal pancreatitis mimicking pancreatic mass:magnetic resonance imaging (MR)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI[J].Acta Radiol,2008,49(5):490-497.DOI:10.1080/02841850802014602. [12] Shen SH,Chiou YY,Wang JH,et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer[J].Am J Roentgenol,2008,190(2):481-488.DOI:10.2214/AJR.07.2155. [13] King AD,Ahuja AT,Yeung DKW,et al. Malignant cervical lymphadenopathy:diagnostic accuracy of diffusion-weighted MR imaging[J].Radiology,2007,245(3):806-813.DOI:10.1148/radiol.2451061804. [14] Takahara T,Imai Y,Yamashita T,et al. Diffusion weighted whole body imaging with background body signal suppression (DWMRIBS):technical improvement using free breathing,STIR and high resolution 3D display[J].Radiat Med,2004,22(4):275-282. [15] Niwa T,Ueno M,Ohkawa S,et al. Advanced pancreatic cancer:the use of the apparent diffusion coefficient to predict response to chemotherapy[J].Br J Radiol,2009,82(973):28-34.DOI:10.1259/bjr/43911400. [16] Arvold ND,Niemierko A,Mamon HJ,et al. Pancreatic cancer tumor size on CT scan versus pathologic specimen:implications for radiation treatment planning[J].Int J Radiat Oncol Biol Phys,2011,80(5):1383-1390.DOI:10.1016/j.ijrobp.2010.04.058. [17] 曾复,葛春林.胰腺癌185例诊治回顾分析[J].中国普通外科杂志,2015,24(3):336-342.DOI:10.3978/j.issn.1005-6947.2015.03.006. Zeng F,Ge CL.Diagnosis and treatment of pancreatic cancer:a retrospective analysis of 185 cases[J].Chin J Gen Surg,2015,24(3):336-342.DOI:10.3978/j.issn.1005-6947.2015.03.006. [18] 洪建平,左长京.肝脏转移瘤影像学检查进展[J].实用医学影像杂志,2013,14(1):63-65.DOI:10.3969/j.issn.1009-6817.2013.01.023. Hong JP,Zuo CHJ.Advances in imaging examination of liver metastases[J].J Pract Med Imag,2013,14(1):63-65.DOI:10.3969/j.issn.1009-6817.2013.01.023. [19] 韩若冰,王轩.磁共振弥散加权成像在胰腺癌放疗中的研究进展[J].肿瘤研究与临床,2015,27(9):643-646.DOI:10.3760/cma.j.issn.1006-9801.2015.09.019. Han RB,Wang X.Research progress of diffusion-weighted magnetic resonance imaging in radiotherapy of pancreatic cancer[J].Cancer Res Clin,2015,27(9):643-646.DOI:10.3760/cma.j.issn.1006-9801.2015.09.019.
2016, Vol. 25 
